Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Tuesday, July 9, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
6 Ways Maritime AI Is Transforming the Industry in 2024
Quantexa Signs the Armed Forces Covenant to Support Equal Opportunity for…
Natcap Secures $10 Million to Bring Nature into Business Decision-Making
SoCalGas and EVOLOH Research Project Helps Make Hydrogen and Electrolyzer Production…
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
Regel Therapeutics
Regel Therapeutics
Biotechnology
Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer
News Desk
-
June 21, 2024
The Board of Directors of Regel Therapeutics, a gene regulation company, announced that Stephen J. Farr, PhD, begins as Chief Executive Officer (CEO). Dr. Farr served...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
6 Ways Maritime AI Is Transforming the Industry in 2024
How MEMS Automobile Sensors Are Revolutionizing Vehicle Safety
Quantexa Signs the Armed Forces Covenant to Support Equal Opportunity for the Military
Load more
